{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T23:37:05Z","timestamp":1781566625374,"version":"3.54.5"},"reference-count":27,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.transproceed.2020.01.128","type":"journal-article","created":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T07:40:11Z","timestamp":1590046811000},"page":"2520-2523","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Living Donor Preemptive Kidney Transplantation in Tuberous Sclerosis Complex Patient and the Role of Mammalian Target of Rapamycin Inhibitor: A Case Report"],"prefix":"10.1016","volume":"52","author":[{"given":"Agnieszka","family":"Tarasewicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicja","family":"D\u0119bska-\u015alizie\u0144","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Rutkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edyta","family":"Szurowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2020.01.128_bib1","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.2215\/CJN.02480218","article-title":"Opportunities for increasing the rate of preemptive kidney transplantation","volume":"13","author":"Fishbane","year":"2018","journal-title":"CJASN"},{"key":"10.1016\/j.transproceed.2020.01.128_bib2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.12659\/AOT.913126","article-title":"Comparison of clinical outcomes between preemptive transplant and transplant after a short period of dialysis in living-donor kidney transplantation: a propensity-score-based analysis","volume":"24","author":"Kim","year":"2019","journal-title":"Ann Transplant"},{"key":"10.1016\/j.transproceed.2020.01.128_bib3","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1038\/nrdp.2016.35","article-title":"Tuberous sclerosis complex","volume":"2","author":"Henske","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.transproceed.2020.01.128_bib4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13023-018-0870-y","article-title":"Incidence of tuberous sclerosis and age at first diagnosis: new data and emerging trends from a national, prospective surveillance study","volume":"13","author":"Ebrahimi-Fakhari","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.transproceed.2020.01.128_bib5","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/1756287216641353","article-title":"Optimal treatment of tuberous sclerosis complex associated renal angiomyolipomata: a systematic review","volume":"8","author":"Bissler","year":"2016","journal-title":"Ther Adv Urol"},{"key":"10.1016\/j.transproceed.2020.01.128_bib6","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.urology.2016.04.027","article-title":"Long-term clinical morbidity in patients with renal angiomyolipoma associated with tuberous sclerosis complex","volume":"95","author":"Bissler","year":"2016","journal-title":"Urology"},{"key":"10.1016\/j.transproceed.2020.01.128_bib7","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1080\/03007995.2017.1313726","article-title":"Natural history of patients with tuberous sclerosis complex related renal angiomyolipoma","volume":"33","author":"Song","year":"2017","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.transproceed.2020.01.128_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.20452\/pamw.14821","article-title":"Tuberous sclerosis complex or cancer? The radiologist\u2019s point of view, in Problems of nephrooncology. Proceedings from the 1st Scientific and Training Conference Nephrooncology 5-6 October 2018, Gda\u0144sk, Poland","volume":"129","author":"Tarasewicz","year":"2019","journal-title":"Pol Arch Intern Med"},{"key":"10.1016\/j.transproceed.2020.01.128_bib9","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1093\/ndt\/14.4.988","article-title":"End-stage renal failure in adults with the tuberous sclerosis complex","volume":"14","author":"Clarke","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2020.01.128_bib10","first-page":"2019","article-title":"Deceased donor renal transplantation combined with bilateral nephrectomy in a patient with tuberous sclerosis and renal failure","volume":"6","author":"Novotny","year":"2019","journal-title":"Case Rep Transplant"},{"key":"10.1016\/j.transproceed.2020.01.128_bib11","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1016\/j.transproceed.2009.06.227","article-title":"Rapamycin as a therapy of choice after renal transplantation in a patient with tuberous sclerosis complex","volume":"41","author":"Tarasewicz","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2020.01.128_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.20452\/pamw.14821","article-title":"Tuberous sclerosis complex or cancer? The nephrologist\u2019s point of view, in Problems of nephrooncology. Proceedings from the 1st Scientific and Training Conference Nephrooncology 5-6 October 2018, Gda\u0144sk, Poland","volume":"129","author":"Tarasewicz","year":"2019","journal-title":"Pol Arch Intern Med"},{"key":"10.1016\/j.transproceed.2020.01.128_bib13","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/oxfordjournals.ndt.a027315","article-title":"Chronic renal failure and its treatment in tuberous sclerosis","volume":"11","author":"Schillinger","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2020.01.128_bib14","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2147\/IJNRD.S123638","article-title":"Early manifestations of renal disease in patients with tuberous sclerosis complex","volume":"10","author":"Malaga-Dieguez","year":"2017","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"10.1016\/j.transproceed.2020.01.128_bib15","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1007\/s00467-018-4003-6","article-title":"Renal progression factors in young patients with tuberous sclerosis complex: a retrospective cohort study","volume":"33","author":"Janssens","year":"2018","journal-title":"Pediatr Nephrol"},{"issue":"Suppl","key":"10.1016\/j.transproceed.2020.01.128_bib16","first-page":"675","article-title":"Manifestations of renal disease in adult patients with tuberous sclerosis complex-reference center experience [Abstract]","volume":"29","author":"Tarasewicz","year":"2018","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2020.01.128_bib17","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1093\/ndt\/gfy132","article-title":"Effect of everolimus on renal function in patients with tuberous sclerosis complex: evidence from EXIST-1 and EXIST-2","volume":"34","author":"Bissler","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2020.01.128_bib18","first-page":"307","article-title":"Tailoring the \u201cperfect fit\u201d for renal transplant recipients with end-stage polycystic kidney disease: indications and timing of native nephrectomy","volume":"31","author":"Argyrou","year":"2017","journal-title":"In\u00a0Vivo"},{"key":"10.1016\/j.transproceed.2020.01.128_bib19","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1093\/ndt\/gfm552","article-title":"Combined nephrectomy and pre-emptive renal transplantation in a tuberous sclerosis patient with angiomyolipoma, renal carcinoma and life-threatening abdominal hemorrhages","volume":"22","author":"Corsenca","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2020.01.128_bib20","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/iju.13534","article-title":"Spontaneous reduction of native kidney size involving angiomyolipoma lesions in a kidney transplant recipient with tuberous sclerosis complex","volume":"25","author":"Sasaki","year":"2018","journal-title":"Int J Urol"},{"key":"10.1016\/j.transproceed.2020.01.128_bib21","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1016\/j.transproceed.2018.03.028","article-title":"Efficacy and safety of mammalian target of rapamycin inhibitor use-long-term follow-up of first tuberous sclerosis complex patient treated de novo with sirolimus after kidney transplantation: a case report","volume":"50","author":"Tarasewicz","year":"2018","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2020.01.128_bib22","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1016\/j.transproceed.2014.09.065","article-title":"Everolimus in immunosuppressive treatment after kidney transplantation in a patient with tuberous sclerosis: case report","volume":"46","author":"Tarasewicz","year":"2014","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2020.01.128_bib23","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1365-2133.2008.08677.x","article-title":"The mTOR inhibitor rapamycin significantly improves facial angiofibroma lesions in a patient with tuberous sclerosis","volume":"159","author":"Hofbauer","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.transproceed.2020.01.128_bib24","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1432-2277.2009.01041.x","article-title":"Sirolimus in renal transplant recipients with tuberous sclerosis complex: clinical effectiveness and implications for innate immunity","volume":"230","author":"Haidinger","year":"2010","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2020.01.128_bib25","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.trre.2010.11.001","article-title":"Targeting the dysregulated mammalian target of rapamycin pathway in organ transplantation: killing 2 birds with 1 stone","volume":"25","author":"Haidinger","year":"2011","journal-title":"Transplant Rev"},{"key":"10.1016\/j.transproceed.2020.01.128_bib26","first-page":"397087","article-title":"Tuberous sclerosis associated with polycystic kidney disease: effects of rapamycin after renal transplantation","author":"Rosado","year":"2013","journal-title":"Case Rep Transplant"},{"key":"10.1016\/j.transproceed.2020.01.128_bib27","doi-asserted-by":"crossref","DOI":"10.1101\/mcs.a002220","article-title":"Exceptional response to everolimus in a novel tuberous sclerosis complex-2 mutation-associated metastatic renal-cell carcinoma","volume":"4","author":"Alsidawi","year":"2018","journal-title":"Cold Spring Harb Mol Case Stud"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134519318494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134519318494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:37:19Z","timestamp":1758577039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134519318494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S0041134519318494"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2020.01.128","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Living Donor Preemptive Kidney Transplantation in Tuberous Sclerosis Complex Patient and the Role of Mammalian Target of Rapamycin Inhibitor: A Case Report","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2020.01.128","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}